Developed domain profile
AIC.com
Advancing non-opioid recovery therapies for patients after total knee replacement
Research summary
The profile at a glance.
The classification and value describe the domain asset itself. They do not value or imply availability of any operating business.
Classification confidenceHighAcquisition-signal confidenceLimitedValue confidenceDeveloping
Why TLL classifies it this way
AIC.COM is identified as the current public web identity of Arthritis Innovation Corporation. This current-use classification is separate from TLL's domain-only valuation.
Recorded expansion: Arthritis Innovation Corporation
Read the research methodology →Current digital identity
Website Capture
This is how Arthritis Innovation Corporation is currently represented at AIC.COM.
Identity and market context
AIC.COM Domain Overview
Arthritis Innovation Corporation is a pharmaceutical biotechnology company developing non-opioid, long-acting injectable therapies for pain and inflammation after total knee replacement. Its lead program, F14, is an intra-articular anti-inflammatory intended to address post-operative inflammation and support pain and functional recovery; the program is in active Phase 3 development. AIC.com serves as the company’s primary online identity, presenting its mission, technology, product-development information, partnership and contact opportunities, and corporate disclosures in one official destination.
Identity details
- Organization
- Arthritis Innovation Corporation
- Identity role
- Primary identity
- Industry
- Technology
- Source
- Open current-use source ↗
Estimated AIC.COM domain value
$150,000–$349,999AIC is a polished initialism with broad potential in computing, automation, infrastructure, education, and analytics. Its AI opening supplies contemporary conceptual flexibility, while C is common, clear, and easy to type. The combination lacks a single exact word or universal sequence, but its balanced appearance and strong acronym utility give it solid standalone commercial breadth.
Intrinsic score46/100Marketability gradeEModel statusDirectional estimate
Directional estimate of the domain asset, separate from the current brand or business. Existing trademark associations may limit practical transferability.Related opportunities
Similar Domains With Acquisition Signals
These domains are privately held and may require direct outreach or brokerage to acquire.
Analyst note
AIC.com is a compact three-letter domain whose initials map directly to the verified name Arthritis Innovation Corporation. The sequence is easy to parse as A-I-C when spoken, with three distinct letter sounds and a clean uppercase visual form. Its brevity supports quick recall, while the capitalized presentation makes the initialism immediately legible. “Innovation” gives the middle I a meaningful role rather than leaving AIC as an unexplained code. Paired with .com, AIC has the concise, formal structure expected of a corporate pharmaceutical identity; the live site uses that shorthand consistently.Asset-only research estimate · 2026
Comparable identities
Comparable Developed Identities
DomainAgents
Acquisition partnerResearch the Domain.
Research the Domain.
Contact the Owner.
DomainAgents has facilitated more than 300,000 domain negotiations since 2012.
TLL is free and has no subscription. Owner outreach costs $19.95. When a buyer-initiated acquisition completes, DomainAgents charges a 10% buyer success fee, reduced to 7.5% above $25,000. Public TLL estimates use public signals; private negotiation data is not used.
Explore DomainAgents ↗Keep exploring
Explore Another 3-Letter .com
Search any three-letter combination to see its profile and estimated value.